SINGAPORE, Sept. 26, 2011 /PRNewswire/ -- Novus Scientific today announced TIGR® Matrix Surgical Mesh, the world's first and only long-term resorbable mesh, as an alternative to permanent synthetic mesh. First introduced in the US in 2010, TIGR® Matrix Surgical Mesh is currently being used in many surgical applications as an alternative to permanent synthetic mesh and expensive biologic devices.

Characteristics of TIGR® Matrix Surgical Mesh
TIGR® Matrix Surgical Mesh is knitted from two different synthetic absorbable fibers, possessing different degradation characteristics. The first fiber, making up approximately 40% of the matrix by weight, is a copolymer of glycolide, lactide, and trimethylene carbonate. The second fiber, making up approximately 60% of the matrix by weight, is a copolymer of lactide, and trimethylene carbonate. Both fibers degrade by bulk hydrolysis once implanted.

Based on the product's absorption characteristics, in vitro testing showed that the first fiber retains its functional capabilities for 1-2 weeks and in vivo studies in the abdominal wall of sheep showed that the first fiber was fully absorbed after 4 months. The same in vitro testing showed that the second fiber retains its functional capabilities for 6 months and in vivo studies in the abdominal wall of sheep indicated that the second fiber is completely absorbed after approximately 36 months.

"We at Novus Scientific have long prided ourselves on identifying clinical need and developing innovative products to address that need. We are pleased to highlight the fact that TIGR® Matrix Surgical Mesh is a viable alternative to permanent synthetic mesh on both a physiological treatment level and a budgetary level when used by physicians performing surgeries that reinforce soft tissue where weakness exists," said Thomas Engstrom, Founder and CEO of Novus Scientific.

"Surgeons want to provide the best treatment for their patients. Now, TIGR® Matrix Surgical Mesh offers surgeons an alternative to non-absorbable synthetic mesh," commented James Archetto, President of Novus Scientific, Inc.

Mark Swierzewski, MD, a urological surgeon from Tampa, FL stated, "TIGR® Matrix has been a part of my practice since 2010. It provides me and my patients with a viable alternative to non-absorbable synthetic mesh."

About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of absorbable synthetic medical devices. Visit our PRESSROOM: http://www.mynewsdesk.com/pressroom/novus-scientific

TIGR® is a trademark of Novus Scientific Pte. Ltd

CONTACT:
jim.archetto@novusscientific.com
781-577-2599

SOURCE Novus Scientific

Back to top

RELATED LINKS
http://www.novusscientific.com